Showing results (151-160 of 582) with videos related to
Sort By:
Pageof 59
Journal of Medicinal Chemistry|December 22, 2006
Synthesis, in vitro antiviral evaluation, and stability studies of novel alpha-borano-nucleotide analogues of 9-[2-(phosphonomethoxy)ethyl]adenine and (R)-9-[2-(phosphonomethoxy)propyl]adenineKarine Barral, Stéphane Priet, Joséphine Sire, et al.Antimicrobial Agents and Chemotherapy|September 10, 2014
The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replicationAloys Tijsma, David Franco, Simon Tucker, et al.The Journal of Antimicrobial Chemotherapy|June 23, 2012
Replication capacity of minority variants in viral populations can affect the assessment of resistance in HCV chimeric replicon phenotyping assaysThierry Verbinnen, Tom Jacobs, Leen Vijgen, et al.Viruses|December 23, 2023
A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus InhibitorsXinyu Wang, Winston Chiu, Hugo Klaassen, et al.Antiviral Research|February 26, 2008
R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyondBert Thys, Armando M De Palma, Johan Neyts, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 4, 2021
Cytidine nucleoside analog is an effective antiviral drug against TrichomonasvirusRavi Kumar Narayanasamy, Petr Rada, Alois Zdrha, et al.ACS Infectious Diseases|September 16, 2021
Assessing In Vitro Resistance Development in Enterovirus A71 in the Context of Combination Antiviral TreatmentKristina Lanko, Chenyan Shi, Shivaprasad Patil, et al.Biorxiv : the Preprint Server for Biology|May 27, 2024
The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection modelThuc Nguyen Dan Do, Rana Abdelnabi, Bernadett Boda, et al.Antimicrobial Agents and Chemotherapy|December 24, 2008
Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitorsLotte Coelmont, Suzanne Kaptein, Jan Paeshuyse, et al.Antimicrobial Agents and Chemotherapy|January 25, 2003
Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in micePieter Leyssen, Christian Drosten, Marcus Paning, et al.Pageof 59